Catalyst Pharmaceutical (CPRX)

• Market cap: $2.82B
• 1 day: 2.96%
• 5 days: -0.51%
• 1 month: 3.69%
• 3 months: 18.28%
• 6 months: -2.76%
• Year to date: 9.76%
• 1 year: 10.68%
• 5 years: 516.71%
• 10 years: 884.17%
• Sector: Healthcare
• Industry: Biotechnology

About: Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers three drug products, FIRDAPSE (amifampridine), FYCOMPA (perampanel), and AGAMREE (vamorolone).

Employees: 167